FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology and represents the use of the probiotic strain Lactobacillus rhamnosus and an oligosaccharide mixture which contains 5-70 wt % of at least one N-acetylated oligosaccharides specified in a group containing GalNAcα1,3Galβ1,4Glc and Galβ1,6GalNAcα1,3Galβ,4Glc, 20-90 wt % of at least one neutral oligosaccharide specified in a group containing Galβ1,6Gal, Galβ1,6Galβ1,4Glc Galβ1,6Galβ1,6Glc, Galβ1,3Galβ1,3Glc, Galβ1,3Galβ1,4Glc, Galβ1,6Galβ1,6Galβ1,4Glc, Galβ1,6Galβ1,3Galβ1,4Glc Galβ1,3Galβ1,6Galβ1,4Glc and Galβ1,3Galβ1,3Galβ1,4Glc, and 5-50 wt % of at least one sialylated oligosaccharide specified in a group containing NeuAcα2,3Galβ1,4Glc and NeuAcα2,6Galβ1,4Glc, in producing a sinbiotic composition for stimulating the development of early bifidogenic intestinal microbiota in the infants born by cesarean section.
EFFECT: invention provides effective stimulation of the development of early bifidogenic intestinal microbiota in the infants born by cesarean section, reducing a risk of the following allergy, and as preventing and treating diarrhoeia in the infants born by cesarean section.
15 cl, 2 ex, 1 tbl, 3 dwg
